Offene Stellen bei ResMed in allen Ländern und Bereichen
Digital Health Technology (DHT) is ResMed’s innovative technology center. This global team is continuously fixated on improving outcomes with a relentless focus on what our patients need today and what will enhance their quality of life in the future. We are courageous and look to build success together. We do things because they are right, not because they are familiar and we inspire others to come on the journey. We hope future team members see opportunity in every obstacle that comes up.
We are “Data People” engaged, curious and innovative. Our teams are made up of Product Development, Digital Platform Engineering, Data Science & AI, Delivery Enablement, IT Services, and Business Analytics. “It’s inspiring to see what happens when you bring passionate people together and give them the freedom to explore ideas” Kate Molony, Senior Director, Connected Health Innovation
Urvashi Tyagi was appointed Chief Technology Officer in February 2022, responsible for leading the company’s Digital Health Technology team to drive its world-leading cloud-based digital health platforms, as well as investments in emerging technologies including artificial intelligence and machine learning.
Urvashi has over 25 years’ experience in software development and delivery, product strategy, finance, business development, and executive leadership. Before joining ResMed, she was chief technology officer and senior vice president for ADP, responsible for its technology vision and strategy, products modernization, and enterprise technology. She was also the global head of commercial data engineering for American Express, along with senior roles at Amazon’s Audible, Microsoft, and IBM.
Urvashi serves on advisory boards of Worcester Polytechnic Institute (WPI) in Massachusetts and CIONET. She holds a Master’s in information technology from WPI; an MBA in finance and entrepreneurship from South Gujarat University in Surat, India; and a Bachelor’s in mechanical engineering from Sardar Patel University in V.V.Nagar, India.
Lucile Blaise was appointed ResMed’s President of Sleep & Respiratory Care in July 2022, responsible for leading for its core business: providing cloud-connectable devices as well as masks and other accessories to millions of people worldwide living with sleep apnea, COPD, asthma, or other chronic diseases.
Lucile is a medtech industry thought leader with over 25 years’ experience. She was previously ResMed’s Vice President of Sleep & Respiratory Care for Western Europe starting in 2015, where she not only guided the region’s growth strategy, but was instrumental in helping establish public payer market access and reimbursement for telemonitoring in France and Belgium, and telemedicine in France. Before that, she served as Vice President of France and North Africa from 2012 to 2015, and in various ResMed marketing and sales roles within the Sleep & Respiratory Care business going back to 2006.
Lucile is president of the Snitem, France’s premier medtech industry association where she’s served as a board member since 2016. She’s also a board member at MedTech Europe.
Lucile holds a business degree from the KEDGE Business School in Talence, France, and a Bachelor of Arts in international business from the University of Sheffield in England. She speaks four languages: French, English, Spanish, and German.
Bobby Ghoshal was appointed President of ResMed’s SaaS business in August 2021, in addition to his role as chief technology officer (CTO), which he’s held since April 2018. He previously served as chief operating officer for Brightree, a ResMed-owned provider of cloud-based software-as-a-service for out-of-hospital care: delivering improved clinical and business performance for homecare customers. Prior to that Bobby led the information technology function for the US, Canada, and Latin America commercial teams, driving adoption of digital platforms and data analytics across the enterprise.
Bobby has more than 25 years’ experience in technology across multiple industries including finance, semiconductors and healthcare, working for companies including Freescale Semiconductor, Motorola, Compuware and Wipro Infotech. Bobby has helped build and lead high-performance teams in information technology, semiconductor innovation, digital and business strategy, information security, advanced analytics, operations and customer care.
Bobby holds a Master of Business Administration degree from Arizona State University and a bachelor’s degree in electronics engineering and telecommunications from the National Institute of Technology (NIT) in Calicut, India.
Frau Vered Keisar wurde im März 2021 zum Chief People Officer von ResMed ernannt und ist für die Förderung der globalen Unternehmenskultur und Personalstrategie verantwortlich. Zuvor war sie als Vizepräsident und General Counsel für die Regionen Asien und Lateinamerika von ResMed tätig.
Frau Keisar verfügt über mehr als 25 Jahre umfassende Branchenerfahrung, welche vom Gesundheitswesen und der Pharmazie bis hin zur Verteidigung und Versicherung reicht. Bevor sie 2012 in das Unternehmen ResMed eintrat, arbeitete sie in führenden Anwaltskanzleien in Großbritannien, Australien, Japan und Israel.
Frau Keisar ist als Rechtsanwältin in England und Wales, Australien und Israel zugelassen. Sie hat einen MBA von der Sydney Graduate School of Management, ein Diploma of Laws in European Competition Law vom King’s College in London und einen Bachelor of Laws vom College of Management Academic Studies in Israel.
Von 2016 bis 2020 wurde Frau Vered zur Vorsitzenden des australischen Diversity and Inclusion Committee der Association of Corporate Counsel gewählt, der weltweit größten Organisation für Unternehmensjuristen mit mehr als 45.000 Mitgliedern in über 85 Ländern.
Seit 2012 ist Frau Vered Keisar Botschafterin und Sprecherin für die Australian National Breast Cancer Foundation.